BRIXADI (BUPRENORPHINE)

**Product type:** Human Prescription Drug

**Active ingredient:** BUPRENORPHINE

**Strength:** 128 mg/.36mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Braeburn Inc.

**Marketing category:** NDA (NDA210136)

**Pharmacologic class:** Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]

**DEA schedule:** CIII